Studies in mice indicate that targeting antigens to dendritic cells (DCs) can elicit strong CD4+T cell responses. In this Opinion article, the authors summarize the existing DC-targeting approaches; they discuss whether these vaccines are superior to current vaccines and what future studies should entail to successfully introduce these vaccines into a clinical setting.
- Wolfgang Kastenmüller
- Kathrin Kastenmüller
- Robert A. Seder
